Additionally, it is well known that once insulin treatment is established, adequate levels of portal insulin are obtained at the expense of peripheral hyperinsulinemia, which may have an impact on various organs and tissues (e.g., bone). The gene discussed is INS; the disease is Hyperinsulinemia.